BILL · 2011–12 SESSION

HB 1397: Medicaid agency/generics

Requiring the state medicaid agency to establish a competitive bid process for generic drug manufacturers.

Summary

  • Establishes the medicaid generic drug competition and savings act. Directs the department of social and health services, as the state medicaid agency, to require certain generic drug manufacturers to compete in a competitive bid process to ensure that the agency is providing medicaid recipients with quality generic products at a competitively bid low cost.

From the Bill Digest (HB 1397), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 20, 2011
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Tami Green (D-28)
Introduced
January 20, 2011 in the House
Last action
April 11, 2012

AN ACT Relating to requiring the state medicaid agency to establish a competitive bid process for generic drug manufacturers;

Sponsors

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. By resolution, reintroduced and retained in present status.
  3. By resolution, reintroduced and retained in present status.
  4. By resolution, reintroduced and retained in present status.
  5. By resolution, reintroduced and retained in present status.
  6. First reading, referred to Health Care & Wellness.

HB 1397 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page